Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared to their White counterparts, data suggest.

More than 63 million Americans are caregivers for a family member with complex medical needs, according to a new report.

Among patients with grade group 1 prostate cancer, those belonging to higher risk groups were more likely to have adverse pathology and die from their disease.

There have been 402 “attacks on science” in the first 6 months of President Donald Trump’s second term, a new report suggests.

Use of GLP-1 receptor agonists is associated with a lower risk of death than use of DPP4 inhibitors in older patients with cancer and type 2 diabetes, data suggest.

The head of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has stepped down after less than 3 months in the role.

Critics of most-favored-nation drug pricing have warned that it could reduce patient access to certain drugs, raise the prices of other drugs, and decrease research and development for new drugs.

The gender pay gap for US physicians hit 26% in 2024, which was an increase from the 23% pay gap observed in 2023, according to a report.

New research suggests that the survival benefits observed with different treatments for advanced melanoma vary according to the site of metastasis.

Cancer patients may face multiple legal challenges that impede their access to care, research suggests.

Hospital officials are warning that changes in President Donald Trump’s budget and tax bill put them on an unsustainable track that could lead to closures or loss of services in rural communities.

Community oncology practices in the US have been experiencing drug shortages that seriously impact cancer care delivery, a survey suggests.